Finoso Pharma Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2009.
2009 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Finoso Pharma Private Limited

Finoso Pharma Private Limited, a active private limited company, was established on 18 August 2009 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24231TG2009PTC064774. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.50 Cr and a paid-up capital of ₹3.02 Cr.

It upholds a compliant status. Employing 15 professional, Its leadership includes Aparna Bidarkar (Director), Kunapareddy Devi Prasad (Additional Director), Phaninder Nath Peta Sonti (Additional Director). Past directors included Sandeep Varalwar, Vaidyanathan Mulandram Nateshan, Prashanthi Alamuru. It holds ₹4.50 Cr open charges and ₹2.45 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sp Biotech Park - Phase-I, Block-I Turkapally, Shameerpet Mandal, Hyderabad, Telangana, 500078.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231TG2009PTC064774

  • Registration Number

    064774

  • Incorporation Date

    18 August 2009

  • Authorized Capital

    ₹3.50 Cr

  • Paid-Up Capital

    ₹3.02 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.50 Cr
  • Paid Up Capital ₹ 3.02 Cr
  • Company Age 16 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.50 Cr
  • Satisfied Charges ₹ 2.45 Cr
  • Revenue Growth **** 71.24%
  • Profit Growth **** 39.87%
  • Ebitda **** 29.29%
  • Net Worth -4.01%
  • Total Assets **** 8.68%
Company report

Finoso Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Finoso Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Finoso Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Aparna Bidarkar Director 05 Jun 2025 Current
Kunapareddy Devi Prasad Additional Director 08 Mar 2024 Current
Phaninder Nath Peta Sonti Additional Director 16 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2015 Past
Pramod Abcsdd Director 01 Jan 2010 Past
Pramod Abcsdd Director 02 Feb 2015 Past
Pramod Abcsdd Additional Director 22 Feb 2022 Past
Pramod Abcsdd Additional Director 22 Feb 2022 Past
Pramod Abcsdd Additional Director 14 Jul 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Finoso Pharma.

Finoso Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 71.24% increase. The company also saw a substantial improvement in profitability, with a 39.87% increase in profit. The company's net worth dipped by a decrease of 4.01%.

Finoso Pharma revenue growth over time
Finoso Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 71.24%
*******
*******
*******
*******
Revenue from Operations
*******
 71.52%
*******
*******
*******
*******
Total Assets
*******
 8.68%
*******
*******
*******
*******
Profit or Loss
*******
 39.87%
*******
*******
*******
*******
Net Worth
*******
 -4.01%
*******
*******
*******
*******
EBITDA
*******
 29.29%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Finoso Pharma?

In 2023, Finoso Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹45,000,000.00

Satisfied Charges

₹24,500,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 4.50 Cr
Latest Charge Details
Date Lender Amount Status
31 Dec 2014 State Bank Of India ₹4.50 Cr Open
28 Oct 2009 State Bank Of India ₹2.45 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Finoso Pharma?

Finoso Pharma has a workforce of 15 employees as of Aug 07, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Finoso Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finoso Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Finoso Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Finoso Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    The activity Phaninder Nath Peta Sonti was appointed as a Additional Director was appointed as a Additional Director on 16 Jul 2025 & has been associated with this company since 6 months 29 days . was completed.

  • Director Appointment

    Progress on Aparna Bidarkar was appointed as a Director was appointed as a Director on 05 Jun 2025 & has been associated with this company since 8 months 8 days . was documented.

  • Balance Sheet

    Finoso Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    Progress on Kunapareddy Devi Prasad was appointed as a Additional Director was appointed as a Additional Director on 08 Mar 2024 & has been associated with this company since 1 year 11 months . was documented.

  • Charges

    The activity A charge with State Bank Of India of Rs. 4.50 Cr registered on 31 Dec 2014 with Charge ID 10549154 was modified on 08 Nov 2017. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Finoso Pharma Private Limited?

The CIN of Finoso Pharma Private Limited is U24231TG2009PTC064774.

Where is Finoso Pharma Private Limited headquartered?

Finoso Pharma Private Limited is headquartered at Sp Biotech Park - Phase-I, Block-I Turkapally, Shameerpet Mandal, Hyderabad, Telangana, 500078.

When was Finoso Pharma Private Limited incorporated?

Finoso Pharma Private Limited was incorporated on 18 August 2009.

Who are the current directors of Finoso Pharma Private Limited?

The current directors of Finoso Pharma Private Limited are

What is the primary industry of Finoso Pharma Private Limited?

The primary industry of Finoso Pharma Private Limited is Professional, Scientific And Technical.

Is Finoso Pharma Private Limited a listed company?

Finoso Pharma Private Limited is unlisted.

What is the capital structure of Finoso Pharma Private Limited?

The authorized capital of Finoso Pharma Private Limited is ₹3.50 Cr, and the paid-up capital is ₹3.02 Cr.

What is the compliance status of Finoso Pharma Private Limited?

The compliance status of Finoso Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available